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Abstract
Purpose—Adequate velopharyngeal control is essential for speech, but may be impaired in
Parkinson’s disease (PD). Bilateral subthalamic nucleus deep brain stimulation (STN DBS)
improves limb function in PD, but the effects on velopharyngeal control remain unknown. We
tested whether STN DBS would change aerodynamic measures of velopharyngeal control, and
whether these changes were correlated with limb function and stimulation settings.
Methods—Seventeen PD participants with bilateral STN DBS were tested within a morning
session after a minimum of 12 h since their most recent dose of anti-PD medication. Testing
occurred when STN DBS was on, and again 1 h after STN DBS was turned off, and included
aerodynamic measures during syllable production, and standard neurological ratings of limb
function.
Results—We found that PD participants exhibited changes with STN DBS, primarily consistent
with increased intraoral pressure (n = 7) and increased velopharyngeal closure (n = 5). These
changes were modestly correlated with measures of limb function, and were correlated with
stimulation frequency.
Conclusion—Our findings suggest that STN DBS may change velopharyngeal control during
syllable production in PD, with greater benefit associated with low frequency stimulation.
However, DBS demonstrates a more subtle influence on speech-related velopharyngeal control
than limb motor control. This distinction and its underlying mechanisms are important to consider
when assessing the impact of STN DBS on PD.
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Learning outcomes: As a result of this activity, the participant will be able to (1) describe the effects of deep brain stimulation on
limb and speech function; (2) describe the effects of deep brain stimulation on velopharyngeal control; and (3) discuss the possible
reasons for differences in limb outcomes compared with speech function with deep brain stimulation of the subthalamic nucleus.
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Parkinson’s disease (PD) affects more than 1 million individuals in the United States,
resulting in impairment of limb motor control, including deficits in force recruitment,
velocity, and acceleration of limb movements (DeLong, 1990, 2000; Desmurget et al., 2004;
Pfann, Buchman, Comella, & Corcos, 2001; Pfann et al., 2004; Robichaud, Pfann,
Vaillancourt, Comella, & Corcos, 2005). Most individuals with PD will develop impairment
of speech motor control, including abnormal respiratory, laryngeal, and supralaryngeal
control for breathing and speech (Baker, Ramig, Luschei, & Smith, 1998; Barlow, Iacono,
Paseman, Biswas, & D’Antonio, 1998; Gallena, Smith, Zeffiro, & Ludlow, 2001; Hunker,
Abbs, & Barlow, 1982; Luschei, Ramig, Baker, & Smith, 1999). The Unified Parkinson’s
Disease Rating Scale (UPDRS, Fahn & Elton, 1987) is a commonly employed assessment
tool for PD that correlates well with more specific measures of limb motor function
(Robichaud et al., 2005; Vaillancourt et al., 2006). However, the UPDRS is primarily a
measure of limb-related function and only includes two speech-related items that correlate
weakly with specific measures of speech function (Richards, Marder, Cote, & Mayeaux,
1994). Therefore, in assessing disease severity and the potential influence of intervention on
PD, it would be valuable to efficiently sample and index specific speech-related physiology.
Adequate intraoral air pressure is essential for speech, and is often substantially decreased in
PD (Bunton, 2005; Solomon & Hixon, 1993; Tamaki, Matsuo, Yanagihara, & Abe, 2000;
Tzelepis, McCool, Friedman, & Hoppin, 1988). Velopharyngeal function may be less
commonly recognized as a problem in PD. However, several reports described significant
velopharyngeal impairment in PD including decreased velopharyngeal closure and increased
transnasal air flow (Darley, Aronson, & Brown, 1975; Hirose, Kiritani, Ushijima, Yoshioka,
& Sawashima, 1981; Hoodin & Gilbert, 1989a, 1989b; Logemann, Fisher, Boshes, &
Blonsky, 1978; Robbins, Logemann, & Kirschner, 1986). Intraoral air pressure deficits and
velopharyngeal impairments in PD may contribute to reduced speech audibility, linguistic
confusion, and communicative impairment. Because these cranial systems are negatively
impacted by PD, it is important to examine their response to interventions such as deep brain
stimulation (DBS). However, the effects of DBS on intraoral pressure and velopharyngeal
control are unknown.
In order to achieve appropriate intraoral pressure and oral resonance during production of a
simple syllable such as , air flow should be directed through the mouth, and air flow
through the nasal cavity should be negligible. Conservative estimates suggest that adequate
approximation of the soft palate (velum) with the lateral and posterior pharyngeal wall
should result in a velopharyngeal orifice area of less than 5 mm2, and nasal air flow of less
than 125 cc/s (Baken & Orlikoff, 2000; Dalston & Warren, 1986; Dalston, Warren & Smith,
1990; Thompson & Hixon, 1979;Warren, 1964, 1967a, 1967b;Warren & DuBois, 1964;
Zajac & Mayo, 1996). Air pressure during speech may be assessed directly through a
polyethylene tube in the oral cavity during simple speech production such as in the syllable
 (Smitheran & Hixon, 1981). Air flow during speech may be measured directly through
a nasal mask placed over the nose during syllable production. The nasal air flow signal
provides information regarding velopharyngeal closure. Intraoral pressure and nasal air flow
can be used together to estimate velopharyngeal area (Lotz, Shaughnessy, & Netsell, 1981;
Netsell, Lotz, & Shaughnessy, 1982;Warren & DuBois, 1964). Therefore, measuring air
pressure and air flow during syllable production provides a simple, non-invasive assessment
to examine changes in velopharyngeal control with DBS. However, the degree to which
these aerodynamic measures of velopharyngeal function are affected by STN DBS in PD is
unknown.
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During the past decade, deep brain stimulation (DBS) of the subthalamic nucleus (STN) has
rapidly emerged as a treatment for advanced idiopathic Parkinson’s disease (PD) (Breit,
Schulz, & Benabid, 2004; Volkmann, 2004;Weaver et al., 2009). STN DBS involves
stereotactic neurosurgical placement (typically bilateral) of a quadripolar stimulating
electrode into the sensorimotor region of the subthalamic nucleus, and surgical placement of
an implantable pulse generator (IPG) subcutaneously in the pectoral region of the chest.
Following surgery, the clinician may program the IPG to select the stimulation frequency,
pulse width, and voltage, and the combination of active contacts on the quadripolar
electrode. The primary goal of STN DBS is to achieve optimal clinical benefit for limb-
related function, as typically evaluated using the UPDRS. DBS has been associated with
marked improvements in limb motor function and overall quality of life (Vaillancourt et al.,
2006; Vaillancourt, Prodoehl, Metman, Bakay, & Crocos, 2004). However, earlier speech-
related studies of STN DBS revealed different outcomes (D’Alatri et al., 2008; Dromey,
Kumar, Lang, & Lozano, 2000; Farrell, Theodoros, Ward, Hall, & Silburn, 2005; Gentil,
Chauvin, Pinto, Pollak, & Benabid, 2001; Gentil, Garcia-Ruiz, Pollak, & Benabid, 1999;
Hoffman-Ruddy, Schulz, Vitek, & Evatt, 2001; Klostermann et al., 2008; Pinto, Gentil,
Fraix, Benabid, & Pollak, 2003; Pinto et al., 2004, 2005;Rousseaux et al., 2004; Santens, De
Letter, Van Borsel, De Reuck, & Caemaert, 2003; Wang, Metman, Bakay, Arzbaecher, &
Bernard, 2003; Wang et al., 2006) (see reviews: Barlow & Hammer, 2009; Jones, Kendall,
Sudhyadhom, & Rosenbek, 2007; Schulz & Grant, 2000;Trail et al., 2005). For example,
some groups reported significant improvements in speech following bilateral STN DBS
(Gentil et al., 2001), some reported modest improvements that did not reach functional
significance (Dromey et al., 2000; Farrell et al., 2005), and others reported significant
degradation of speech function (Klostermann et al., 2008). Non-speech studies demonstrated
improvements in force recruitment and precision of upper lip, lower lip, and tongue
movement in PD participants with STN DBS(Gentil et al., 1999; Pinto et al., 2003, 2004).
Extended improvements up to 5 years following the initiation of STN DBS were described
for isometric lip and tongue force control, but were also accompanied by increasingly severe
dysarthria (Pinto et al., 2003).
The reasons for the different responses of speech, non-speech, and limb function to STN
DBS may be due to the different functional requirements. High frequency STN DBS is
optimized for limb-related function, as typically determined by the UPDRS, and the
localization and programming of the DBS electrodes are optimized for limb-related
somatotopy. However, improving the ability to generate larger magnitudes of force, as
reported in the limb and orofacial force studies, may be of less benefit for the complex, low-
level forces that are required for speech and voice (Barlow & Muller, 1991; Bunton &
Weismer, 1994; Montgomery, 2007; Tornqvist, Schalen, & Rehncrona, 2005). Moreover,
these differences are further reflected by the observation that speech may benefit more from
low frequency stimulation than high frequency stimulation (Montgomery, 2007; Tornqvist et
al., 2005). However, no studies known to these authors have examined changes in
aerodynamic measures of speech-related velopharyngeal control in PD with STN DBS, or
whether these changes may be associated with stimulation parameters (e.g., frequency, pulse
width, voltage) or measures of limb function (e.g., UPDRS).
The first objective of this study was to examine the effects of bilateral STN DBS on
aerodynamic measures of velopharyngeal control in PD participants. Based on the
heterogeneity of participant responses reported in previous studies, we expected to observe
individual increases and decreases for each of the three aerodynamic measures with DBS.
However, we also wanted to examine if the heterogeneity of responses might be related to
DBS simulation parameters, as suggested by earlier reports (Montgomery, 2007; Tornqvist
et al., 2005), and if speech-related velopharyngeal control was related to limb function.
Accordingly, our second objective was to test whether there was a significant association
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between stimulation parameters (e.g., frequency, pulse width, voltage) and standard
neurological ratings of limb function (e.g., UPDRS) with changes in the aerodynamic
measures of velopharyngeal function.
2. Methods
2.1. Participants
This investigation was conducted in accordance with NIH regulations for the ethical
treatment of human subjects. The protocol in this investigation was approved by the local
institutional ethics committee for the safety of human subjects. Participants were informed
of the general purposes of the study and written informed consent was obtained prior to
enrolling any participants in the study. Data were collected from 17 individuals (14 men and
3 women) with advanced idiopathic PD, an average of 12 years since diagnosis, a minimum
of 3 months since bilateral STN DBS surgery (Table 1), with a mean age of 59 years. Each
individual also participated in a separate experiment focused on respiratory and laryngeal
control (Hammer, Barlow, Lyons, & Pahwa, 2010).
2.2. Background testing
Testing was coordinated with the participant’s scheduled neurological evaluation. Each
participant was tested during a single morning session a minimum of 12 h since their most
recent dose of anti-PD medication. During the scheduled evaluation, each participant
underwent post-operative neurological assessment (DBS ON only) by a movement disorder
specialist (R.P.) including the motor scale of the UPDRS, Hoehn and Yahr (H&Y) staging,
and the Schwab and England Activities of Daily Living Scale (S&E) (Fahn & Elton, 1987;
Hoehn & Yahr, 1967; Schwab & England, 1968). This post-operative neurological
assessment (DBS ON, no medication) was compared with the most recent pre-operative
assessment (no medication). Participants exhibited significant pre- vs. post-operative
improvement in standard neurological ratings of limb function with STN DBS (UPDRS, t =
−5.05, p < .001; H&Y, t = −2.38, p < .04; S&E, t = 4.93, p < .001). Individual neurological
assessment scores are in Table 1. DBS stimulation parameters (e.g., frequency, pulse width,
voltage) are provided in Table 2
After carefully considering our participants and the limited availability for testing during
their scheduled post-operative neurological evaluations, we chose to assess velopharyngeal
function by sampling intraoral pressure and transnasal airflow with DBS on, and again 1 h
after DBS was turned off. We examined whether changes in the standard neurological
ratings of limb function (e.g., UPDRS, pre- vs. post-operative) were associated with changes
in measures of velopharyngeal function (DBS ON vs. DBS OFF), and whether changes in
velopharyngeal function were associated with DBS stimulation parameters (e.g., frequency).
2.3. Air pressure and air flow
Participants were comfortably seated in an exam chair and instructed to repeat the syllable
 at a rate of 2 syllables per second at a comfortable pitch and loudness. Intraoral air
pressure was measured directly using a polyethylene catheter (Intramedic PE 260, 1.77 mm
ID, 7 cm length) placed in the mouth near the oral angle and oriented perpendicular to the
breath stream during speech (Smitheran & Hixon, 1981). The catheter was coupled to a
pressure transducer (Honeywell model 164PC01D37). A 10 cm H2O pressure source (U-
tube manometer) was used to calibrate the air pressure transducer. Air flow was measured
using a Hans Rudolph nasal respiratory mask (model CR1650) and pneumotachometer
(model R4719) instrumented with a pressure transducer (model 163PC01D36). A 500 cc/s
air flow source (Glottal Enterprises model MCU-2) was used to calibrate the air flow
transducer. Both air pressure and air flow signals were conditioned by bridge amplifiers
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(Biocommunications Electronics, model 201, LP −3 dB @ 50 Hz, Butterworth 3-pole). Lip
closure was carefully monitored for each participant. Only syllables with complete seal of
the lips during consonant production were included in analysis. Signals were digitized at 3.3
kHz using a custom designed data acquisition and analysis program to compute intraoral
pressure (PO) and nasal air flow (Barlow, Suing, & Andreatta, 1999). We used the pressure
and air flow values to compute velopharyngeal (VP) area (Baken & Orlikoff, 2000; Lotz et
al., 1981; Netsell et al., 1982; Warren & DuBois, 1964).
2.4. Statistical analyses
Based on the heterogeneity of participant responses reported in previous studies, we
expected to observe individual increases and decreases for each of the three aerodynamic
measures with DBS such that traditional group analysis (paired t-tests DBS ON vs. DBS
OFF, α = .05/3 measures = .017) would not reflect significant changes. We expected that
individual PD participants would exhibit significant absolute changes in each measure, and
used the individual change data (Table 3) to compute the group mean magnitude of change
and the group standard error for each measure. We then examined whether individuals
exhibited an absolute magnitude of change that exceeded 2 times the group standard error,
and used this as our criterion for significance (Fig. 1).
Next, we compared our data with typical operating ranges reported in the literature for each
of the three aerodynamic measures (Baken & Orlikoff, 2000; Dalston & Warren, 1986;
Dalston et al., 1990; Netsell & Hixon, 1978; Smitheran & Hixon, 1981; Thompson & Hixon,
1979; Warren, 1964, 1967a, 1967b; Warren & DuBois, 1964; Zajac & Mayo, 1996). We
examined the individual baselines, responses to DBS, and examined whether individual
values approached, departed from, or stayed within the typical operating range with DBS
(Table 4, Fig. 1).
To test whether the heterogeneity of speech-related responses was related to DBS simulation
parameters (e.g., frequency) and standard neurological ratings of limb function (e.g.,
UPDRS), we calculated Pearson product moment correlation coefficients (α = .05).
3. Results
Individual values and corresponding change for each aerodynamic measure of
velopharyngeal control are shown in Fig. 1, and are summarized in Table 3. As expected, we
observed individual increases and decreases for each of the three aerodynamic measures
with DBS such that traditional group analysis (paired t-tests DBS ON vs. DBS OFF, all p-
values >.05) did not reflect significant changes. However, individual PD participants
exhibited changes in each measure (Table 4 and Fig. 1): PO (n = 10), nasal air flow (n = 8),
and VP area (n = 6). Of these participants, most exhibited beneficial increases in PO (n = 7),
with decreases in nasal airflow (n = 5) and VP area (n = 5) (Table 4). These changes, though
relatively modest, were primarily consistent with increased intraoral pressure and increased
velopharyngeal closure. In addition, PD participants exhibited distinct individual responses
to STN DBS. For example, of the 10 PD participants who exhibited changes in PO with STN
DBS, 7 manifested increased PO while 3 exhibited decreased PO.
Next, we compared our data with typical operating ranges reported in the literature for each
of the three aerodynamic measures (Fig. 1) (Baken & Orlikoff, 2000;Dalston & Warren,
1986;Dalston et al., 1990;Netsell & Hixon, 1978;Smitheran & Hixon, 1981;Thompson &
Hixon, 1979;Warren, 1964,1967a,1967b;Warren & DuBois, 1964;Zajac & Mayo, 1996) to
examine the individual baselines, responses to DBS, and whether individual values
approached, departed from, or stayed within a typical operating range with DBS (Table 4).
For example, one PD participant (1) that exhibited PO below the typical range (OFF)
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approached but overshot the typical range with DBS. Very few PD participants exhibited
values beyond the typical range with DBS OFF, and most exhibited values within the typical
range for each measure with DBS on. Therefore, most PD participants exhibited modest
changes and most exhibited measures within the typical range with STN DBS.
Finally, we examined the degree to which changes in each aerodynamic measure was
associated with stimulation parameters (e.g., frequency) and changes in standard
neurological ratings of limb function (e.g., UPDRS, H&Y). We found moderate correlations
(all p-values <.05) between stimulation frequency of the right STN with PO (r = −.50) and
between stimulation frequency of the left STN with VP area (r = .49). We also found that
PO was moderately correlated with the UPDRS (r = .60) and H&Y (r = .50), and VP area
was moderately correlated with the H&Y (r = −.50) (Pearson product–moment correlation
coefficients, all p-values <.05). Therefore, changes in aerodynamic measures of PO and VP
area were related to DBS stimulation frequency and modestly paralleled standard
neurological ratings of limb function.
4. Discussion
This study presents the first data examining the effects of bilateral STN DBS on
velopharyngeal control in PD, and how these effects relate to changes in ratings of limb
function (e.g., UPDRS) and DBS stimulation parameters (e.g., frequency). We observed
relatively subtle changes in aerodynamic measures of speech velopharyngeal control with
STN DBS. As expected, we observed individual increases and decreases for each of the
three aerodynamic measures with DBS, consistent with the heterogeneity of speech-related
responses described previously. However, most of the changes we observed in these PD
participants were generally consistent with increased PO and increased velopharyngeal
closure.
We also examined if the heterogeneity of changes in speech-related velopharyngeal control
might be related to DBS simulation parameters, as suggested by earlier reports
(Montgomery, 2007; Tornqvist et al., 2005) and found that the speech-related responses
were related to DBS simulation frequency. We observed a moderate negative correlation
between stimulation frequency of the right STN with change in PO and a moderate positive
correlation between stimulation frequency of the left STN with change in VP area,
indicating that lower frequency stimulation may be associated with greater PO and smaller
VP area. These correlations are consistent with previous observations that the complex, fine
forces employed during speech may benefit more from low frequency stimulation than high
frequency stimulation (Barlow & Muller, 1991; Bunton & Weismer, 1994; Montgomery,
2007; Tornqvist et al., 2005), and further suggest a differential effect of STN DBS for
speech-related velopharyngeal control and limb-related control. The oscillatory patterns of
the basal ganglia-thalamocortical network that influence speech, including velopharyngeal
control, may operate at lower resonant frequencies, and therefore respond more positively to
low frequency DBS (Montgomery, 2007). An earlier report also noted a differential effect
for pulse width and voltage (Tripoliti et al., 2008). We did not observe this effect in the
present study. Finally, the correlations observed in the present study may also confirm
previously reported hemispheric effects (Santens et al., 2003;Wang et al., 2003, 2006). It is
possible that stimulation of the right STN may have more influence on PO and stimulation of
the left STN may exert more influence on VP closure.
Changes in speech-related aerodynamic measures of velopharyngeal function with STN
DBS may reflect changes in central scaling of speech-related regulation of intraoral pressure
and velopharyngeal control. When we observed improvements, it may be that abnormally
altered patterns of neural firing presumed to occur throughout the basal ganglia-
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thalamocortical network may approximate a more normal pattern of oscillation with DBS. It
is also possible that these abnormal patterns may be more amenable to beneficial
compensation by remaining healthy brain tissue in the presence of DBS. However, the
changes we observed were relatively subtle. In fact, most of the aerodynamic changes were
within normal limits. These relatively modest changes may relate to the fact that these
participants received high frequency DBS over a fairly narrow range of stimulation
frequencies (145–185 Hz). In addition to stimulation frequency, several other factors may
account for the modest changes and correlations we observed including variability in
localization of the active DBS electrodes, stimulation fields and potential current spread
beyond the STN target (e.g., internal capsule), individual variability in somatotopic
organization of STN, hemispheric interactions (Santens et al., 2003;Wang et al., 2003,
2006), and differences in pre-treatment speech severity (Dromey et al., 2000; Farrell et al.,
2005).
We observed that changes in the speech-related measures modestly paralleled limb-related
changes (e.g., UPDRS), indicating that lower levels of PD limb severity may be associated
with increased PO and decreased VP area. The modest strength of these correlations is not
surprising given that, for example, the UPDRS is weighted almost entirely for limb function,
and lacks the detail to accurately and reliably assess the speech-related subsystems (Miller et
al., 2007; Miller, Noble, Jones, Allcock, & Burn, 2008; Richards et al., 1994). Because of
the limitations of standard neurological ratings of limb-related function to identify change in
speech-related function, we would suggest a need to further integrate speech physiology
measures within neurological assessments to accurately assess even subtle speech related
changes in participants with neurological diseases such as PD. Aerodynamic measures of
velopharyngeal control may be useful within a more comprehensive battery of speech-
related measures to index potential changes in motor control associated with STN DBS in
PD. Clinical neurological assessment scales focus almost exclusively on limb motor
function and do not offer specific indices to detect subtle changes in speech-related motor
control that may signal the onset and progression of a disease, and its potential response to
treatment. Therefore, the development, refinement, and employment of clinically relevant
measures of speech-related physiology, including aerodynamic assessment of
velopharyngeal control, may be useful during neurological assessment of individuals with
PD.
One limitation of the present study was that we only included post-operative speech testing
(DBS ON vs. DBS OFF) using syllables, and correlated these speech changes with pre- vs.
post-operative changes in limb function. Using these different time points for comparison
may be misleading. Therefore, we would suggest inclusion of pre- and postoperative testing
for comparison, to examine the potential influence of pre-treatment speech severity, and
inclusion of assessments of phrases and sentences. We would also suggest that future studies
consider repeating the standard neurological ratings of limb function with STN DBS turned
off, to directly compare limb function DBS ON vs. DBS OFF, and include electrode
coordinates with stimulation parameters to correlate with speech and limb function. A
second limitation of this study was that we did not include other instrumental or perceptual
measures of resonance or intelligibility. Therefore, future study designs should consider
integration of speech aerodynamics within a more comprehensive instrumental assessment
(e.g., laryngoscopy, nasometry, and perceptual ratings).
5. Conclusion
The effects of STN DBS on speech-related velopharyngeal control in PD were previously
unknown. In our study, we applied non-invasive aerodynamic techniques to examine
speech-related velopharyngeal function. We found that bilateral STN DBS may influence
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velopharyngeal control during syllable production in PD. However, bilateral STN DBS
demonstrates a more subtle effect on speech-related velopharyngeal control than for limb
motor control. The effects on velopharyngeal control are not uniform across participants and
only modestly correlate with changes in limb-related function. Our findings suggest that
speech-related velopharyngeal control may benefit more from low frequency stimulation
than high frequency stimulation. The distinctions between speech and limb-related function,
and between high vs. low frequency stimulation, are important to consider when assessing
the impact of STN DBS on PD, and may be valuable to guide clinicians in the optimization
of DBS stimulation parameters for individuals with PD.
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Appendix A. Continuing education
1. The Unified Parkinson’s Disease Rating Scale (UPDRS) is
a. A commonly employed assessment tool for Parkinson’s disease
b. Correlates well with specific measures of limb motor function
c. Includes only two speech-related items
d. Correlates weakly with specific measures of speech function
e. All of the above
2. Deep brain stimulation has been associated with
a. Marked improvements in limb function
b. Consistent improvements in speech and voice
c. Improved quality of life
d. All of the above
e. a and c
3. The article demonstrated
a. A significant group effect of deep brain stimulation on velopharyngeal
control
b. No significant group effect of deep brain stimulation on velopharyngeal
control
c. Significant individual effects of deep brain stimulation on velopharyngeal
control
d. The relatively subtle effects of deep brain stimulation on velopharyngeal
control
e. The influence of heterogeneity of outcomes on group design
f. a, c, d, and e
g. b, c, d, and e
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4. The article demonstrated that intraoral air pressure and velopharyngeal area
correlated with
a. Stimulation frequency
b. Stimulation inter-stimulus interval
c. Stimulation pulse width
d. Stimulation rise time
e. Stimulation voltage
5. Possible reasons for reported differences in limb outcomes compared with speech
function with deep brain stimulation of the subthalamic nucleus include
a. Variability in localization of the active electrodes
b. Potential current spread beyond the subthalamic nucleus
c. Individual variability in somatotopic organization of the subthalamic
nucleus
d. Differences in stimulation effects on each hemisphere
e. Differences in pre-treatment speech severity
f. Optimization of DBS settings and localization for limb rather than speech
function
g. All of the above
References
Baken, RJ.; Orlikoff, RF. Clinical measurement of speech and voice. San Diego: Singular Publishing
Group Inc.; 2000.
Baker KK, Ramig LO, Luschei ES, Smith ME. Thyroarytenoid muscle activity associated with
hypophonia in Parkinson disease and aging. Neurology 1998;51:1592–1598. [PubMed: 9855507]
Barlow, SM.; Hammer, MJ. Pallidotomy and deep brain stimulation in Parkinson’s disease: Effects on
speech and voice. In: McNeil, M., editor. The clinical management of sensorimotor speech
disorders. New York: Thieme Medical Publishers; 2009. p. 362-364.
Barlow, SM.; Iacono, RP.; Paseman, LA.; Biswas, A.; D’Antonio, LD. The effects of experimental
posteroventral pallidotomy on force and speech aerodynamics in Parkinson’s disease. In: Cannito,
MP.; Yorkston, KM.; Beukelman, DR., editors. Speech motor control. Baltimore: Paul H. Brookes
Publishing Company; 1998. p. 117-156.
Barlow SM, Muller EM. The relation between interangle span and in vivo resultant force in the
perioral musculature. Journal of Speech and Hearing Research 1991;34:252–259. [PubMed:
2046349]
Barlow, SM.; Suing, G.; Andreatta, RD. Speech aerodynamics using AEROWIN. In: Barlow, SM.,
editor. Handbook of clinical speech physiology. San Diego: Singular Publishing Group Inc.; 1999.
p. 165-190.
Breit S, Schulz JB, Benabid A-L. Deep brain stimulation. Cell and Tissue Research 2004;318:275–
288. [PubMed: 15322914]
Bunton K. Patterns of lung volume use during an extemporaneous speech task in persons with
Parkinson disease. Journal of Communication Disorders 2005;38:331–348. [PubMed: 15963334]
Bunton K, Weismer G. Evaluation of a reiterant force-impulse task in the tongue. Journal of Speech
and Hearing Research 1994;37:1020–1031. [PubMed: 7823548]
D’Alatri L, Paludetti G, Contarino MF, Galla S, Marchese MR, Bentivoglio AR. Effects of bilateral
subthalamic nucleus stimulation and medication on parkinsonian speech impairment. Journal of
Voice 2008;22:365–372. [PubMed: 17368837]
Hammer et al. Page 9













Dalston RM, Warren DW. Comparison of Tonar II, pressure-flow, and listener judgments of
hypernasality in the assessment of velopharyngeal function. Cleft Palate Journal 1986;23:108–115.
[PubMed: 3516454]
Dalston RM, Warren DW, Smith LR. The aerodynamic characteristics of speech produced by normal
speakers and cleft palate speakers with adequate velopharyngeal function. Cleft Palate Journal
1990;27:393–401. [PubMed: 2253387]
Darley, F.; Aronson, A.; Brown, J. Motor speech disorders. Philadelphia: Singular Publishing Group
Inc.; 1975.
DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends in Neuroscience
1990;13:281–285.
DeLong, MR. Basal ganglia. In: Kandel, E.; Schwartz, J.; Jessel, T., editors. Principles of neural
science. New York: McGraw-Hill; 2000. p. 853-867.
Desmurget M, Gaveau V, Vindras P, Turner RS, Broussolle E, Thobois S. On-line motor control in
patients with Parkinson’s disease. Brain 2004;127:1755–1773. [PubMed: 15215215]
Dromey C, Kumar R, Lang AC, Lozano AM. An investigation of the effects of subthalamic nucleus
stimulation on acoustic measures of voice. Movement Disorders 2000;15:1132–1138. [PubMed:
11104196]
Fahn, S.; Elton, R. Members of the UPDRS development committee. In: Fahn, S.; Marsden, CD.;
Calne, DB.; Goldstein, M., editors. Recent developments in Parkinson’s disease. Florham Park,
NJ: Macmillian Health Care Information; 1987. p. 153-163.p. 293-304.
Farrell A, Theodoros D, Ward E, Hall B, Silburn P. Effects of neurosurgical management of
Parkinson’s disease on speech characteristics and oromotor function. Journal of Speech Language
Hearing Research 2005;48:5–20.
Gallena S, Smith PJ, Zeffiro T, Ludlow CL. Effects of levodopa on laryngeal muscle activity for voice
onset and offset in Parkinson disease. Journal of Speech Language Hearing Research
2001;44:1284–1299.
Gentil M, Chauvin P, Pinto S, Pollak P, Benabid AL. Effect of bilateral stimulation of the subthalamic
nucleus on parkinsonian voice. Brain and Language 2001;78:233–240. [PubMed: 11500072]
Gentil M, Garcia-Ruiz P, Pollak P, Benabid AL. Effect of stimulation of the subthalamic nucleus on
oral control of patients with parkinsonism. Journal of Neurology Neurosurgery and Psychiatry
1999;67:329–333.
Hammer MJ, Barlow SM, Lyons KE, Pahwa R. Subthalamic nucleus deep brain stimulation changes
speech respiratory and laryngeal control in Parkinson’s disease. Journal of Neurology. 2010 doi:
10.1007/s00415-010-5605-5.
Hirose H, Kiritani S, Ushijima T, Yoshioka H, Sawashima M. Patterns of dysarthric movements in
patients with parkinsonism. Folia Phoniatrica et Logopedia 1981;33:204–215.
Hoehn MM, Yahr MD. Parkinsonism: Onset, progression and mortality. Neurology 1967;17:427–442.
[PubMed: 6067254]
Hoffman-Ruddy B, Schulz G, Vitek J, Evatt M. A preliminary study of the effects of subthalamic
nucleus (STN) deep brain stimulation (DBS) on voice and speech characteristics in Parkinson’s
disease (PD). Clinical Linguistics and Phonetics 2001;15:97–101.
Hoodin RB, Gilbert HR. Nasal airflows in parkinsonian speakers. Journal of Communication
Disorders 1989a;22:169–180. [PubMed: 2738191]
Hoodin RB, Gilbert HR. Parkinsonian dysarthria: An aerodynamic and perceptual description of
velopharyngeal closure for speech. Folia Phoniatrica et Logopedia 1989b;41:249–258.
Hunker CJ, Abbs JH, Barlow SM. The relationship between Parkinsonian rigidity and hypokinesia in
the orofacial system: A quantitative analysis. Neurology 1982;32:755–761.
Jones HN, Kendall DL, Sudhyadhom A, Rosenbek JC. The effects of lesion therapy and deep brain
stimulation on speech function in patients with Parkinson’s disease. Communicative Disorders
Review 2007;1:133–173.
Klostermann F, Ehlen F, Vesper J, Nubel K, Gross M, Marzinzik F, et al. Effects of subthalamic deep
brain stimulation in dysarthrophonia in Parkinson’s disease. Journal of Neurology Neurosurgery
and Psychiatry 2008;79:522–529.
Hammer et al. Page 10













Logemann JA, Fisher HB, Boshes B, Blonsky ER. Frequency and cooccurrence of vocal tract
dysfunctions in the speech of a large sample of Parkinson patients. Journal of Speech and Hearing
Disorders 1978;43:47–57. [PubMed: 633872]
Lotz WK, Shaughnessy AL, Netsell R. Velopharyngeal and nasal cavity resistance during speech
production. Abstracts from the American Speech Language hearing association annual convention.
1981
Luschei ES, Ramig LO, Baker KL, Smith ME. Discharge characteristics of laryngeal single motor
units during phonation in young and older adults and in persons with Parkinson disease. Journal of
Neurophysiology 1999;81:2131–2139. [PubMed: 10322054]
Miller N, Allcock L, Jones D, Noble E, Hildreth AJ, Burn DJ. Prevalence and pattern of perceived
intelligibility changes in Parkinson’s disease. Journal of Neurology Neurosurgery and Psychiatry
2007;78:1188–1190.
Miller N, Noble E, Jones D, Allcock L, Burn DJ. How do I sound to me? Perceived changes in
communication in Parkinson’s disease. Clinical Rehabilitation 2008;22:14–22. [PubMed:
18089662]
Montgomery EB. Deep brain stimulation and speech: A new model of speech function and dysfunction
in Parkinson’s disease. Journal of Medical Speech Language Pathology 2007;15:9–25.
Netsell R, Hixon TJ. A noninvasive method for clinically estimating subglottal pressure. Journal of
Speech and Hearing Disorders 1978;43:326–330. [PubMed: 692098]
Netsell, R.; Lotz, WK.; Shaughnessy, AL. Abstracts from the association for research in
otolaryngology. 1982. Nasal cavity resistance estimates during vocalization.
Pfann KD, Buchman AS, Comella CL, Corcos DM. Control of movement distance in Parkinson’s
disease. Movement Disorders 2001;16:1048–1065. [PubMed: 11748736]
Pfann KD, Robichaud JA, Gottlieb GL, Comella CL, Brandabur M, Corcos DM. Muscle activation
patterns in point-to-point and reversal movements in healthy, older subjects and in subjects with
Parkinson’s disease. Experimental Brain Research 2004;157:67–78.
Pinto S, Gentil M, Fraix V, Benabid AL, Pollak P. Bilateral subthalamic stimulation effects on oral
force control in Parkinson’s disease. Neurology 2003;250:179–187.
Pinto S, Ozsancak C, Tripoliti E, Thobois S, Limousin-Dowsey P, Auzou P. Treatments for dysarthria
in Parkinson’s disease. Lancet Neurology 2004;3:547–556. [PubMed: 15324723]
Pinto S, Gentil M, Krack P, Sauleau P, Fraix V, Benabid AL, et al. Changes induced by levodopa and
subthalamic nucleus stimulation on parkinsonian speech. Movement Disorders 2005;20:1507–
1515. [PubMed: 16037917]
Richards M, Marder K, Cote L, Mayeaux R. Interrater reliability of the Unified Parkinson’s Disease
Rating Scale motor examination. Movement Disorders 1994;9:89–91. [PubMed: 8139610]
Robbins JA, Logemann JA, Kirschner HS. Swallow and speech production in Parkinson’s disease.
Annals of Neurology 1986;19:283–287. [PubMed: 3963773]
Robichaud JA, Pfann KD, Vaillancourt DE, Comella CL, Corcos DM. Force control and disease
severity in Parkinson’s disease. Movement Disorders 2005;20:441–450. [PubMed: 15593316]
Rousseaux M, Krystkowiak P, Kozlowski O, Ozsancak C, Blond S, Destee A. Effects of subthalamic
nucleus stimulation on parkinsonian dysarthria and speech intelligibility. Neurology
2004;251:327–334.
Santens P, De Letter M, Van Borsel J, De Reuck J, Caemaert J. Lateralized effects of subthalamic
nucleus stimulation on different aspects of speech in Parkinson’s disease. Brain and Language
2003;87:253–258. [PubMed: 14585294]
Schulz GM, Grant MK. Effects of speech therapy and pharmacologic and surgical treatments on voice
and speech in Parkinson’s disease: A review of the literature. Journal of Communication Disorders
2000;33:59–88. [PubMed: 10665513]
Schwab, RS.; England, AC. Projection technique for evaluating surgery in Parkinson’s disease. In:
Gillingham, FJ.; Donaldson, IML., editors. Third symposium on Parkinson’s disease, Royal
College of Surgeons in Edinburgh. Edinburgh: E. & S. Livingstone; 1968. p. 152-157.
Smitheran JR, Hixon TJ. A clinical method for estimating laryngeal airway resistance during vowel
production. Journal of Speech and Hearing Disorders 1981;46:138–146. [PubMed: 7253590]
Hammer et al. Page 11













Solomon NP, Hixon TJ. Speech breathing in Parkinson’s disease. Journal of Speech and Hearing
Research 1993;36:294–310. [PubMed: 8487522]
Tamaki A, Matsuo Y, Yanagihara T, Abe K. Influence of thoracoabdominal movement on pulmonary
function in patients with Parkinson’s disease: Comparison with healthy subjects.
Neurorehabilitation and Neural Repair 2000;14:43–47. [PubMed: 11228948]
Thompson AE, Hixon TJ. Nasal air flow during normal speech production. Cleft Palate Journal
1979;16:412–420. [PubMed: 290432]
Trail M, Fox C, Ramig LO, Sapir S, Howard J, Lai EC. Speech treatment for Parkinson’s disease.
Neurorehabilitation 2005;20:205–221. [PubMed: 16340101]
Tornqvist AL, Schalen L, Rehncrona S. Effects of different electrical parameter settings on the
intelligibility of speech in patients with Parkinson’s disease treated with subthalamic deep brain
stimulation. Movement Disorders 2005;20:416–423. [PubMed: 15593314]
Tripoliti E, Zrinzo L, Martinez-Torres I, Tisch S, Frost E, Borrell E, et al. Effects of contact location
and voltage amplitude on speech and movement in bilateral subthalamic nucleus deep brain
stimulation. Movement Disorders 2008;16:2377–2383. [PubMed: 18785648]
Tzelepis GE, McCool DF, Friedman JH, Hoppin FG. Respiratory muscle dysfunction in Parkinson’s
disease. American Review of Respiratory Disease 1988;138:266–271. [PubMed: 3195826]
Vaillancourt DE, Prodoehl J, Metman LV, Bakay RA, Crocos DM. Effects of deep brain stimulation
and medication on bradykinesia and muscle activation in Parkinson’s disease. Brain
2004;127:491–504. [PubMed: 14662520]
Vaillancourt DE, Prodoehl J, Sturman MM, Bakay RAE, Verhagen LV, Crocos DM. Effects of deep
brain stimulation and medication on strength, bradykinesia, and electromyographic patterns of the
ankle joint in Parkinson’s disease. Movement Disorders 2006;21:50–58. [PubMed: 16124011]
Volkmann J. Deep brain stimulation for the treatment of Parkinson’s disease. Journal of Clinical
Neurophysiology 2004;21:6–17. [PubMed: 15097290]
Wang E, Metman LV, Bakay R, Arzbaecher J, Bernard B. The effect of unilateral electrostimulation of
the subthalamic nucleus on respiratory/phonatory subsystems of speech production in Parkinson’s
disease – A preliminary report. Clinical Linguistics and Phonetics 2003;17:283–289. [PubMed:
12945603]
Wang EQ, Metman LV, Bakay RAE, Arzbaecher J, Bernard B, Corcos DM. Hemisphere-specific
effects of subthalamic nucleus deep brain stimulation on speaking rate and articulatory accuracy of
syllable repetitions in Parkinson’s disease. Journal of Medical Speech Language Pathology
2006;14:323–333. [PubMed: 18270553]
Warren DW. Velopharyngeal orifice size and upper pharyngeal pressure-flow patterns in cleft palate
speech: A preliminary study. Plastic and Reconstructive Surgery 1964;34:15–26. [PubMed:
14200514]
Warren DW. Nasal emission of air and velopharyngeal function. Cleft Palate Journal 1967a;4:148–
155. [PubMed: 5229147]
Warren DW. Oral port constriction, nasal resistance, and respiratory aspects of cleft palate speech: An
analog study. Cleft Palate Journal 1967b;4:39–46.
Warren DW, DuBois AB. A pressure-flow technique for measuring velopharyngeal orifice area during
continuous speech. Cleft Palate Journal 1964;16:52–71. [PubMed: 14116541]
Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ, et al. Bilateral deep brain stimulation vs.
best medical therapy for patients with advanced Parkinson disease: A randomized controlled trial.
Journal of the American Medical Association 2009;301:63–73. [PubMed: 19126811]
Zajac DJ, Mayo R. Aerodynamic and temporal aspects of velopharyngeal function in normal speakers.
Journal of Speech and Hearing Research 1996;39:1199–1207. [PubMed: 8959605]
Hammer et al. Page 12














Individual values for each participant with DBS ON (black symbols) and DBS OFF (gray
symbols). (a) Intraoral pressure (PO), (b) nasal air flow, and (c) velopharyngeal (VP) area.
In each graph, dashed vertical reference lines demarcate boundaries between significant
increases (left), non-significant changes (middle), and significant decreases (right). Solid
horizontal reference lines demarcate a reasonably conservative typical operating range.
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